Counterfeit and substandard drugs jeopardize health and waste money. Andreas Seiter reviews dimensions of the problem and contributing factors, and how countries can ensure drug quality. Pharmaceutical products are attractive candidates for illegal trade, especially in developing countries. They are easily transportable, have high value per unit, and most importantly, their quality cannot be assessed readily by lay persons or even experts without...
انظر المزيد
تفاصيل
-
2005/3/01
-
مذكرة موجزة
-
32192
-
1
-
1
-
2005/5/03
-
Disclosed
-
Pharmaceutical: counterfeits, substandard drugs and drug diversion
-
Counterfeit Drugs